COVID-19 mortality and risk factors in patients with cancer in Ecuador: A retrospective, non-randomized, controlled study

Evelyn Valencia-Espinoza, María Del Carmen Cabezas, Andrea Plaza, Katherine García, Carlos Calle, Marco Fornasini, José Luna, Camila Miño

Producción científica: Contribución a una revistaArtículorevisión exhaustiva


The 2019 coronavirus disease (COVID-19) pandemic has affected different human populations since March 2020 and challenged healthcare systems, especially in chronic non-communicable diseases such as cancer. The present study aimed to evaluate the mortality, risk factors, and symptoms of cancer patients and control subjects, diagnosed with COVID-19 and admitted to intensive care unit (ICU). This retrospective, observational, non-randomized, controlled study of patients admitted to ICU was conducted between March and August 2020 in an Ecuadorian oncology center. Patient information collected from electronic medical records included sociodemographic information, clinical history, symptoms, laboratory test results, COVID-19 treatment, and discharge status. For patients with neoplasia, diagnosis, type, and status of cancer, as well as antineoplastic treatment received over the past month was also recorded. Descriptive statistics and multiple logistic regression were used to analyze the data. Statistical analysis was performed with SPSS (version 22.0) and R (version 4.1.3). In total, 79 adult COVID-19 patients were studied (40 with cancer and 39 controls). The total mean time until COVID-19 symptoms onset was 6.2±3.5 days (5.3±3.2 days in the cancer group vs 7.2±3.6 days in the control group; P=.016) but no difference was observed in reported symptoms. All patients received an antibiotic treatment, but only 70% of the cancer group had antivirals (P<.001). Cancer patients had lower hemoglobin levels than controls (10.7±2.8 vs 13.3±1.7 g/dL; P<.001). In terms of mortality, not statistically significance difference was reported between groups. The study showed that high ferritin (Absolute Odds Ratio of 3.9; 95% CI 1.1-14.6) and mechanical ventilation (Absolute Odds Ratio of 4.9; 95% CI 1.3-18.6) were independent COVID-19 mortality risk factors. COVID-19 infection did not represent an increased risk of mortality in cancer patients, but elevated ferritin levels and the need for mechanical ventilation were identified as mortality risk factors.

Idioma originalInglés
Páginas (desde-hasta)E34082
PublicaciónMedicine (United States)
EstadoPublicada - 23 jun. 2023

Nota bibliográfica

Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.

Citar esto